LHX:NYSEL3Harris Technologies, Inc. Analysis
Data as of 2026-05-22 - not real-time
$306.33
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
L3Harris is trading near a key technical support level while the short‑term moving average sits above the medium‑term average, suggesting a cautiously optimistic bias. The MACD histogram has turned positive and the RSI is in the lower half of its range, indicating limited upside momentum but no immediate oversold condition. Recent earnings showed strong organic revenue growth and a sharp increase in GAAP EPS, reinforcing the company’s growth narrative. Analyst sentiment remains bullish with a consensus buy rating and a median price target substantially above the current price. However, the DCF fair value estimate is far below the market price, flagging a potential valuation disconnect. The balance sheet carries a high debt load relative to equity and free cash flow is currently nil, which raises concerns about dividend sustainability. The sector benefits from stable defense spending but is sensitive to budgetary and regulatory shifts. Overall, the stock presents a mixed picture of solid earnings momentum tempered by valuation and leverage considerations.
The near‑term outlook is shaped by the ability to maintain earnings growth and manage debt while the dividend offers modest income. Investors should watch for any changes in government contracts or fiscal policy that could impact revenue streams. Technical indicators suggest a neutral to slightly bullish stance, but the lack of free cash flow and elevated leverage advise prudence. A disciplined approach that balances the upside potential against valuation and risk factors is advisable.
The near‑term outlook is shaped by the ability to maintain earnings growth and manage debt while the dividend offers modest income. Investors should watch for any changes in government contracts or fiscal policy that could impact revenue streams. Technical indicators suggest a neutral to slightly bullish stance, but the lack of free cash flow and elevated leverage advise prudence. A disciplined approach that balances the upside potential against valuation and risk factors is advisable.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical support level aligns with price
- Positive MACD histogram signals modest momentum
- Dividend provides modest income but sustainability is uncertain
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong organic revenue growth and EPS acceleration
- Analyst consensus buy with a median price target well above current levels
- Defence sector stability offering long‑run demand
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt relative to cash flow may constrain flexibility
- Dividend yield is modest and may face pressure
- Long‑term government contracts underpin revenue resilience
Key Metrics & Analysis
Financial Health
Revenue Growth190.00%
Profit Margin10.37%
P/E Ratio33.3
Debt/Equity34.57
P/B Ratio3.0
Op. Cash Flow$1.7B
Industry P/E29.5
Technical Analysis
TrendNeutral
RSI38.9
Support$296.67
Resistance$328.82
MA 20$309.75
MA 50$335.57
MA 200$312.46
MACDBullish
VolumeDecreasing
Fear & Greed Index91.5
Valuation
Fair Value$184.02
Target Price$381.95
Upside/Downside24.68%
GradeOvervalued
TypeGrowth
Dividend Yield1.63%
Risk Assessment
Beta0.41
Volatility22.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.